REGISTERED
on 09 Aug 2022
Last Applicant/ Owned by
17383 Sunset Blvd., Suite A250
Pacific Palisades
CA
90272
Serial Number
88984193 filed on 30th Aug 2019
Registration Number
6815686 registered on 09th Aug 2022
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
FYARRO
Pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in oncology; pharmaceutical preparations for the treatment of physiological diseases
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in oncology; pharmaceutical preparations for the treatment of physiological diseases
First Use Date in General
21st Feb 2022
First Use Date in Commerce
21st Feb 2022
Mark Details
Serial Number
No 88984193
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 45455-TM1006
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 09th Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
| 06th Jul 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 05th Jul 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 01st Jun 2022 | ASSIGNED TO EXAMINER |
| 06th May 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 06th May 2022 | DIVISIONAL PROCESSING COMPLETE |
| 11th Apr 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 05th Apr 2022 | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST |
| 01st Apr 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |